BRIGHT MINDS BIOSCIENCES INC. (DRUG) Form 6-K — May 27, 2026
Bright Minds Biosciences Inc. announced it will present at the Jefferies Global Healthcare Conference on June 3, 2026, at 4:20 PM EDT. The presentation will be available via live webcast and archived on the company’s investor relations website for 30 days. The company also disclosed the grant of stock options to certain directors, officers, and consultants to purchase an aggregate of 109,000 common shares.
Key figures
- Offering Price
- 83.4
- Shares Offered
- 109000
- Vesting schedule
- 25% annually over 4 years
- Option vesting period
- 5 years
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.